By Maggie Fick LONDON, July 24 (Reuters) – AstraZeneca's long-time CEO Pascal Soriot has rarely put a foot wrong. The company's shares have more that quadrupled in price during his 14-year tenure,
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Wise tumbles after US declines national trust bank application
July 24 (Reuters) - London-listed shares of Wise fell 10% on Friday after the money…
Trump imposes forced labor duties on 60 trading partners
By David Lawder WASHINGTON, July 24 (Reuters) - The Trump administration on Friday imposed new…
New Delhi [India], July 24 (ANI): The Parliamentary Standing Committee on Consumer Affairs, Food and…
